Variability in interferon gamma release assay results and screening for tuberculosis: A way forward?

Annals of the American Thoracic Society

Volumn 11, Issue 8, 2014, Pages 1256-1257

  Schluger, Neil W ^a,b,d   Burzynski, Joseph ^c  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Department of Medicine   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

BACTERIUM DETECTION; DIAGNOSTIC VALUE; EDITORIAL; GENERAL PRACTICE; HEALTH CARE PERSONNEL; HUMAN; INFECTION PREVENTION; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; OCCUPATIONAL LUNG DISEASE; REPRODUCIBILITY; TUBERCULIN TEST; UNITED STATES; BLOOD; TUBERCULOSIS;

HUMANS; INTERFERON-GAMMA; TUBERCULOSIS;

EID: 84912061531     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201408-361ED     Document Type: Editorial

References (12)

1. Tagmouti S, Slater M, Benedetti A, Kik SV, Banaei N, Cattamanchi A, Metcalfe J, Dowdy D, van Zyl Smit R, Dendukuri N, et al. Reproducibility of interferon gamma release assays: a systematic review. Ann Am Thorac Soc 2014;11:1256-1257.
2. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59(RR-5):1-25.
3. Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis 2006;6:47.
4. Stennis NL, Trieu L, Ahuja SD, Harris TG. Estimated prevalence of TB infection among a New York City clinic population using interferon-gamma release assays. Open Forum Infect Dis [online ahead of print] 20 Jun 2014; DOI: 10.1093/ofid/ofu047.
5. Li J, Munsiff SS, Agerton TB. Prevalence of tuberculin skin test positivity in clinical population in New York City. J Immigr Minor Health 2010;12:816-822.
6. Macaraig M, Burzynski J, Varma JK. Tuberculosis control in New York City - a changing landscape. N Engl J Med 2014;370:2362-2365.
7. Banach DB, Harris TG. Indeterminate QuantiFERON® -TB Gold results in a public health clinic setting. Int J Tuberc Lung Dis 2011; 15:1623-1630.
8. Fong KS, Tomford JW, Teixeira L, Fraser TG, van Duin D, Yen-Lieberman B, Gordon SM, Miranda C. Challenges of interferon-g release assay conversions in serial testing of health-care workers in a TB control program. Chest 2012;142:55-62.
9. Gandra S, Scott WS, Somaraju V, Wang H, Wilton S, Feigenbaum M. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers. Infect Control Hosp Epidemiol 2010;31:1279-1285.
10. Joshi M, Monson TP, Woods GL. Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J 2012; 19:84-88.
11. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, et al.; Tuberculosis Epidemiologic Studies Consortium. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 2014;189:77-87.
12. Lambert LA, Pratt RH, Armstrong LR, Haddad MB. Tuberculosis among healthcare workers, United States, 1995-2007. Infect Control Hosp Epidemiol 2012;33:1126-1132.